06Jul 2024
Diabetes patients on GLP-1s instead of insulin have lower cancer risk

Diabetes patients on GLP-1s instead of insulin have lower cancer risk

A study published in JAMA Network Open examined 1.6 million type 2 diabetes patients' medical records and found that those on GLP-1 treatments, like Ozempic, had a significantly lower risk of developing 10 types of obesity-related cancers compared to those on insulin. The study, covering data from March 2005 to November 2018, highlights the potential cancer-preventive benefits of GLP-1 drugs, although further research is needed.

  • #family health
  • #endo-diabetology

Like

Save

Share